Update
$Cyclacel Pharmaceuticals(CYCC.US$ Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
2 MINUTES AGO, 9:15 AM EST
VIA GLOBENEWSWIRE
2 MINUTES AGO, 9:15 AM EST
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
